These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28964393)

  • 1. Practical Management of Immunosuppressants in Dermatology.
    Leis-Dosil VM; Prats-Caelles I
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):24-34. PubMed ID: 28964393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive agents in dermatology. An update.
    Dutz JP; Ho VC
    Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medicamental immunosuppression in dermatology (author's transl)].
    Goerz G; Merk H
    Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for prescribing azathioprine in dermatology.
    Anstey AV; Wakelin S; Reynolds NJ;
    Br J Dermatol; 2004 Dec; 151(6):1123-32. PubMed ID: 15606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
    Assmann T; Ruzicka T
    Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimetabolites and cytotoxic drugs.
    Silvis NG
    Dermatol Clin; 2001 Jan; 19(1):105-18, viii-ix. PubMed ID: 11155576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutics. XI. Immunosuppressive drugs.
    Ashton H; Beveridge GW; Stevenson CJ
    Br J Dermatol; 1970 Aug; 83(2):326-30. PubMed ID: 4916789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of immunosuppressive therapy in non-neoplastic disorders].
    Grob PJ
    Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide in dermatology.
    Kim J; Chan JJ
    Australas J Dermatol; 2017 Feb; 58(1):5-17. PubMed ID: 26806212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoagression and immunosuppression in dermatology. 3. Immunosuppression in autoagressive dermatoses].
    Novotný F
    Cesk Dermatol; 1973 Jan; 48(1):43-9. PubMed ID: 4687385
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunocytes and autoimmune response and suppression.
    McDonald CJ
    J Natl Med Assoc; 1970 May; 62(3):224-6. PubMed ID: 5463234
    [No Abstract]   [Full Text] [Related]  

  • 14. Azathioprine: its uses in dermatology.
    Chavez-Alvarez S; Herz-Ruelas M; Villarreal-Martinez A; Ocampo-Candiani J; Garza-Garza R; Gomez-Flores M
    An Bras Dermatol; 2020; 95(6):731-736. PubMed ID: 33250113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of autoimmune diseases in preconception, pregnancy and lactation.
    Cozzani E; Cioni M; Gariazzo L; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2019 Jun; 154(3):299-304. PubMed ID: 30375218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases.
    Kanatoula DD; Bodner E; Ghoreschi K; Meier K; Solimani F
    J Dtsch Dermatol Ges; 2024 Mar; 22(3):400-421. PubMed ID: 38259085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive agents in Dermatology].
    Bressan AL; Silva RS; Fontenelle E; Gripp AC
    An Bras Dermatol; 2010; 85(1):9-22. PubMed ID: 20464082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists.
    Goyal A; Goyal K; Merola JF
    Am J Clin Dermatol; 2015 Jun; 16(3):179-95. PubMed ID: 25854805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune diseases and immunosuppressive therapy. I. Immunosuppressive agents].
    Delespesse G; Kennes B; Duchateau J
    Acta Clin Belg; 1974; 29(5):321-8. PubMed ID: 4440395
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive agents in dermatology.
    Ho VC; Zloty DM
    Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.